Ms Sylvest joined Novo Nordisk in 1996 as trainee. From 1997 to 2008 Ms Sylvest had roles in headquarters and regions within pricing, health economics, marketing and sales effectiveness. In 2003, she was appointed vice president of sales and marketing effectiveness in Region Europe. From 2008 to 2015 Ms Sylvest headed up affiliates and business areas of growing size and complexity in Europe and Asia and in 2013 she was also appointed corporate vice president. In August 2015 Ms Sylvest was appointed senior vice president and general manager of Novo Nordisk’s Region China. In this role she was responsible for the company’s activities in the mainland, Taiwan and Hong Kong of China. In October 2017 Ms Sylvest was promoted to executive vice president.

Ms Sylvest serves as member of the boards of Argenx SE, the Netherlands, of Danish Crown A/S, and Vice chairman and member of the board of the World Diabetes Foundation, both in Denmark.

  • 2003: Executive MBA in Leadership and Strategy, Scandinavian International Management Institute.
  • 1998: MSc in Economics, University of Southern Denmark.

Ms Sylvest is a Danish national, born November 1972.